World
MOGENRY Gene Therapy: Hope to restore eyesight, new gene therapy in discussion for Retinitis Pigmentosa patients
A new gene therapy has emerged as a ray of hope for patients suffering from the serious eye disease Retinitis Pigmentosa. American biotech company Nanoscope Therapeutics has developed optogenetic gene therapy named MOGENRY. In clinical trials, this treatment has shown improvement in the visual ability of some patients. This disease gradually damages the light sensing […] The post MOGENRY Gene Therapy: Hope to restore eyesight, new gene therapy in discussion for Retinitis Pigmentosa patients appe
AN
Originally published byAnyTV News 30m ago · anytvnews.com
NewsBeagle is a discovery engine. We show the headline, a short source-supplied summary and clear attribution. The complete reporting remains with the publisher.
